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Abstract. 
 
In
 
 Xenopus
 
 embryos, 
 
b
 
-catenin has been 
shown to be both necessary and sufficient for the estab-
lishment of dorsal cell fates. This signaling activity is 
thought to depend on the binding of 
 
b
 
-catenin to mem-
bers of the Lef/Tcf family of transcription factors and 
the regulation of gene expression by this complex. To 
test whether 
 
b
 
-catenin must accumulate in nuclei to es-
tablish dorsal cell fate, we constructed various localiza-
tion mutants that restrict 
 
b
 
-catenin to either the plasma 
membrane, the cytosol, or the nucleus. When overex-
pressed in 
 
Xenopus
 
 embryos, the proteins localize as 
predicted, but surprisingly all forms induce an ectopic 
axis, indicative of inducing dorsal cell fates. Given this 
unexpected result, we focused on the membrane-teth-
ered form of 
 
b
 
-catenin to resolve the apparent discrep-
ancy between its membrane localization and the hy-
pothesized role of nuclear 
 
b
 
-catenin in establishing 
dorsal cell fate. We demonstrate that overexpression of 
membrane-tethered 
 
b
 
-catenin elevates the level of free 
endogenous 
 
b
 
-catenin, which subsequently accumu-
lates in nuclei. Consistent with the hypothesis that it is 
this pool of non–membrane-associated 
 
b
 
-catenin that 
signals in the presence of membrane-tethered 
 
b
 
-cate-
nin, overexpression of cadherin, which binds free 
 
b
 
-cate-
nin, blocks the axis-inducing activity of membrane-
tethered 
 
b
 
-catenin. The mechanism by which ectopic 
membrane-tethered 
 
b
 
-catenin increases the level of en-
dogenous 
 
b
 
-catenin likely involves competition for the 
adenomatous polyposis coli (APC) protein, which in 
other systems has been shown to play a role in degrada-
tion of 
 
b
 
-catenin. Consistent with this hypothesis, mem-
brane-tethered 
 
b
 
-catenin coimmunoprecipitates with 
APC and relocalizes APC to the membrane in cells. 
Similar results are observed with ectopic plakoglobin, 
casting doubt on a normal role for plakoglobin in axis 
specification and indicating that ectopic proteins that 
interact with APC can artifactually elevate the level of 
endogenous 
 
b
 
-catenin, likely by interfering with its deg-
radation. These results highlight the difficulty in inter-
preting the activity of an ectopic protein when it is as-
sayed in a background containing the endogenous 
protein. We next investigated whether the ability of 
 
b
 
-catenin to interact with potential protein partners in 
the cell may normally be regulated by phosphorylation. 
Compared with nonphosphorylated 
 
b
 
-catenin, 
 
b
 
-cate-
nin phosphorylated by glycogen synthase kinase-3 pref-
erentially associates with microsomal fractions express-
ing the cytoplasmic region of N-cadherin. These results 
suggest that protein–protein interactions of 
 
b
 
-catenin 
can be influenced by its state of phosphorylation, in ad-
dition to prior evidence that this phosphorylation mod-
ulates the stability of 
 
b
 
-catenin.
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1. 
 
Abbreviations used in this paper
 
: APC, adenomatous polyposis coli;
GFP, green fluorescent protein; NES, nuclear exclusion sequence; NLS,
nuclear localization sequence; TM, transmembrane; WT, wild-type; Xgsk-3,
 
Xenopus
 
 glycogen synthase kinase-3.
 
b
 
-catenin 
 
is a multifunctional protein involved in both
the regulation of intercellular adhesion and cell signaling
during development (for reviews see Miller and Moon,
1996; Peifer, 1995). These functions are dependent on in-
teractions between 
 
b
 
-catenin and various protein partners,
including members of the cadherin superfamily of cell ad-
hesion molecules (for review see Kemler, 1993; Peifer,
1995), the adenomatous polyposis coli (APC)
 
1
 
 protein
(Rubinfeld et al., 1993; Su et al., 1993), and members of
the Lef/Tcf family of transcription factors (Behrens et al.,
1996; Molenaar et al., 1996). Each of these interactions oc-
curs in a distinct subcellular compartment and reflects dif-
ferent activities of 
 
b
 
-catenin in each compartment of the
cell.
The binding of 
 
b
 
-catenin to Lef/Tcf transcription factors
and their translocation into the nucleus may play an essen-
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tial role in controlling the transcription of genes required
for specification of cell fate during early development of
 
Xenopus
 
 (Behrens et al., 1996; Molenaar et al., 1996; Lara-
bell et al., 1997) and 
 
Drosophila
 
 (Brunner et al., 1997;
Riese et al., 1997; van de Wetering et al., 1997). In 
 
Xeno-
pus
 
 embryos, recent studies demonstrate that there are
dorso–ventral asymmetries in both the levels and subcellu-
lar localization of 
 
b
 
-catenin in cleavage stage blastomeres
(Larabell et al., 1997). Since an amino-terminal site of
 
b
 
-catenin is required for its maximal in vitro phosphoryla-
tion by glycogen synthase kinase 3 (GSK-3) and mutation
of this site stabilizes 
 
b
 
-catenin, it has been hypothesized
that the dorso–ventral differences in 
 
b
 
-catenin levels arise
from lower GSK-3 activity on the prospective dorsal side
of the embryo, resulting in an increase in the pool of dorsal
 
b
 
-catenin (Yost et al., 1996; Larabell et al., 1997). The
mechanism underlying this process may also involve the
stabilization of interactions between 
 
b
 
-catenin and APC
that has been shown to occur in response to Wnt signals in
cultured cells (Papkoff et al., 1996). Since the interaction
of APC with 
 
b
 
-catenin is strongly linked to the regulation
of steady-state 
 
b
 
-catenin levels (Munemitsu et al., 1995;
Papkoff et al., 1996; Hayashi et al., 1997), stabilization of
 
b
 
-catenin/APC complexes might saturate a rate-limiting
step in a degradative pathway and result in the accumula-
tion of newly synthesized 
 
b
 
-catenin in the cytosol on the
dorsal side of the embryo (Larabell et al., 1997). The ele-
vated dorsal pool of 
 
b
 
-catenin would then undergo trans-
location into the nucleus, perhaps via interactions with
Lef/Tcf transcription factors (Behrens et al., 1996; Mo-
lenaar et al., 1996). The presence of 
 
b
 
-catenin in nuclei of
dorsal but not ventral blastomeres presages and likely con-
tributes directly to the activation of dorsal-specific genes
at the onset of zygotic transcription (Larabell et al., 1997),
and the products of these genes then work in a combinato-
rial manner with other signal transduction pathways to
specify dorsal cell fate (for review see Kimelman et al.,
1992).
Given this proposed model of the role of 
 
b
 
-catenin in
the establishment of dorsal cell fates, we sought to test a
prediction of this model: Specification of dorsal cell fate
requires the accumulation of 
 
b
 
-catenin in nuclei rather
than in the cytoplasm or at membranes. Without such in-
formation one cannot exclude the possibility that 
 
b
 
-cate-
nin induces dorsal cell fate by acting in other cellular com-
partments in which it is found, such as in the cytoplasm or
at the plasma membrane (for review see Miller and Moon,
1996). Testing this relationship has recently gained impor-
tance for a second reason. Ectopic expression of plakoglo-
bin in 
 
Xenopus
 
 embryos leads to its accumulation in nuclei
and the induction of dorsal cell fate as observed with 
 
b
 
-cate-
nin. Surprisingly, a form of plakoglobin that cannot enter
nuclei is also active in promoting dorsal cell fate, and the
authors conclude that it functions by anchoring XTcf-3 or
a related factor from acting as a repressor of dorsal cell
fate (Merriam et al., 1997). By analyzing the signaling ac-
tivities of localization mutants of 
 
b
 
-catenin, their affects
on steady-state levels of endogenous 
 
b
 
-catenin, and their
effects on the subcellular localization of endogenous 
 
b
 
-cate-
nin, APC, and XTcf-3, we have reached an alternative
conclusion. Our results are most consistent with the hy-
pothesis that 
 
b
 
-catenin functions in the specification of dor-
sal cell fate in 
 
Xenopus
 
 in a manner dependent upon its
entry into the nucleus.
 
Materials and Methods
 
Expression Constructs
 
All green fluorescent protein (GFP) and myc-tagged 
 
b
 
-catenin constructs
were produced by PCR amplification of full-length wild-type 
 
b
 
-catenin
and subcloning of the resulting PCR product into the CS2
 
1
 
 vector up-
stream from, and in frame with, either a c-myc epitope (Evan et al., 1985)
or GFP (S65T mutant; Heim et al., 1995). Both the nuclear exclusion se-
quence (NES) and nuclear localization sequence (NLS) localization mu-
tants were produced by subcloning sequences encoding either the nuclear
exclusion sequence of rabbit pkI (Wen et al., 1994, 1995) or the nuclear lo-
calization sequence of the SV-40 large T-antigen (Kalderon et al., 1984;
Lanford and Butel, 1984) in frame with the NH
 
2
 
 terminus of 
 
b
 
-catenin.
Both the NES and NLS oligos contained a consensus Kozak sequence
(Kozak, 1984) followed by an AUG translation initiation site. The trans-
membrane 
 
b
 
-catenin mutant was produced by subcloning a fragment of
 
Xenopus
 
 N-cadherin (Detrick et al., 1990) that encodes the translation
start site, signal sequence, and transmembrane (TM) domain in frame
with the NH
 
2
 
 terminus of wt–
 
b
 
-catenin–GFP. TM–
 
b
 
-catenin 1–9 was pro-
duced by PCR amplifying repeats 1–9 of 
 
b
 
-catenin and subcloning this
fragment in frame to the N-cadherin transmembrane. TM–
 
b
 
-catenin 1-myc
was produced by subcloning the N-cadherin TM domain in frame into an
XhoI site of wt–
 
b
 
-catenin–myc.
APC–GFP was produced by PCR amplifying the central portion of a
human APC cDNA (amino acids 1013–2026; full-length human APC
cDNA was kindly provided by Ray White, University of Utah, Salt Lake
City, UT) and subcloning this fragment into a CS2
 
1
 
/GFP vector resulting
in a fusion protein with GFP at the carboxy terminus.
The myc-tagged human plakoglobin construct was kindly provided by
Michael Klymkowsky (University of Colorado, Boulder, CO) (Merriam et
al., 1997) and the HA-tagged XTcf-3 construct was generously provided
by Olivier Destree (Hubrecht Laboratory, Utrecht, The Netherlands)
(Molenaar et al., 1996).
 
Microinjection of Synthetic RNAs and Embryo Culture
 
Capped synthetic RNAs encoding each of the constructs used in this study
were prepared with the Message Machine kit (Ambion, Inc., Austin, TX).
For axis duplication experiments, 250 pg of each RNA was injected into
the two ventral blastomeres at the four-cell stage, and embryos were
reared to stage 40, at which time they were scored for the presence or ab-
sence of a secondary dorsal axis. For Western blot and immunoprecipita-
tion experiments, 1–2 ng of the indicated RNAs were injected into all four
blastomeres at the four-cell stage, and embryos were cultured at room
temperature to stage 7. For intracellular localization experiments, 1–2 ng
of the indicated RNAs were injected into the animal pole of blastomeres
at the two- to four-cell stage, and embryos were cultured to either stage 9
or 10. Where indicated, 10,000–mol wt Oregon Green dextran (1 mg/ml fi-
nal concentration; Molecular Probes, Eugene, OR) was coinjected as a lin-
eage tracer.
 
Animal Cap Explants and Confocal Microscopy
 
Animal cap explants were fixed in 4% paraformaldehyde–PBS for 1–2 h
at room temperature followed by two washes in PBS 
 
1
 
 0.2% Triton X-100
(PBT). After fixation, explants to be stained for endogenous 
 
b
 
-catenin
were washed in MeOH, bleached in 50% MeOH, 30% H
 
2
 
O
 
2
 
, 20% DMSO
overnight at room temperature, and washed twice in MeOH. GFP-labeled
explants were not bleached because the bleaching process eliminates GFP
fluorescence. Antibody staining was performed in PBT supplemented
with 10% goat serum. Antihuman 
 
c-myc
 
 9E10 monoclonal supernatant
was used at a 1:20 dilution, and anti–
 
b
 
-catenin polyclonal antibodies (Yost
et al., 1996) were used at a 1:500 dilution. After incubation with the pri-
mary antibody, explants were washed three times in PBT and incubated
overnight at 4
 
8
 
C with a 1:250 dilution of Cy-3–conjugated secondary anti-
body (Jackson ImmunoResearch, West Grove, PA) in PBT supplemented
with 10% goat serum. After three washes in PBT, explants were mounted
in Vectashield (Vector Laboratories, Burlingame, CA).
Confocal microscopy was performed with a scan head (model MRC- 
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600; Bio-Rad Labs, Hercules, CA) attached to a microscope (model Op-
tiphot-2; Nikon, Inc., Melville, NY). All images were collected with a 60
 
3
 
1.4 NA PlanApo objective. Multicolor images were collected sequentially
with the appropriate filter blocks to ensure that there was no bleed
through between channels. Images were processed using Adobe Photo-
shop software (San Jose, CA).
 
Western Blot and Immunoprecipitation
 
To compare differences in the steady-state levels of endogenous 
 
b
 
-catenin
protein in response to injection of control RNA (GFP) or membrane-teth-
ered 
 
b
 
-catenin RNA, 25 injected embryos at stage 7 were homogenized in
RIPA buffer (10 mM Hepes, pH 7.4, 150 mM NaCl, 2 mM EGTA, 2 mM
EDTA, 1% Triton X-100, 0.5% Na deoxycholate, 0.1% SDS, 1 mM
PMSF, 1 
 
m
 
g/ml leupeptin) at 4
 
8
 
C. Lysates were cleared by spinning for 15
min at 15,000 rpm in a microcentrifuge. An aliquot of this lysate was col-
lected and represents total (T) protein. The remainder of the cleared
lysate was incubated with ConA-Sepharose beads (Pharmacia LKB Bio-
tech., Piscataway, NJ) for 1 hour at 4
 
8
 
C to remove all cadherin-bound
 
b
 
-catenin. The resulting supernatant contains the soluble (S), cytoplasmic
or nuclear, pool of 
 
b
 
-catenin. Protein samples were analyzed by SDS-
PAGE, and blots were probed with anti–
 
b
 
-catenin (1:1,000) and anti–
 
a
 
spectrin (1:1,000; Giebelhaus et al., 1987) antibodies. Immunoblots were
then probed with a HRP-conjugated goat anti–rabbit secondary antibody
(1:10,000; Jackson ImmunoResearch). The HRP signal was visualized by
enhanced chemiluminescence (Amersham Corp., Arlington Heights, IL).
Signals for 
 
b
 
-catenin and 
 
a
 
-spectrin were quantitated from scanned im-
ages using NIH Image. Endogenous 
 
b
 
-catenin levels (total and soluble)
from control-injected and TM–
 
b
 
-catenin–injected embryos were com-
pared after normalization to 
 
a
 
-spectrin. Levels of 
 
b
 
-catenin in controls
was set to 1.0 and levels in TM–
 
b
 
-catenin–injected embryos are expressed
relative to this scale.
To determine if the ectopic TM–
 
b
 
-catenin interacts with endogenous
APC and a cadherin fraction, we performed immunoprecipitation and
ConA precipitation analyses. Stage 7 embryos previously injected with
1.25 ng TM–
 
b
 
-catenin 1-myc were homogenized in lysis buffer (10 mM
Tris, pH 7.4, 150 mM NaCl, 2 mM EDTA, 0.5% NP-40, 1 mM PMSF, 1
 
m
 
g/ml leupeptin) at 4
 
8
 
C. A cleared lysate was prepared by spinning the
crude homogenates at 15,000 rpm for 15 min in a microcentrifuge. For
APC immunoprecipitation, the cleared lysate was precleared for 1 h at
4
 
8
 
C with protein A–Sepharose beads to eliminate proteins that bind non-
specifically to the beads. The lysates were then incubated with anti-APC
polyclonal antibodies (Näthke et al., 1996) bound to protein A–Sepharose
beads or control protein A–Sepharose beads for 1 h at 4
 
8
 
C. After five
washes in lysis buffer, samples were resuspended in SDS sample buffer.
For ConA precipitation, cleared lysates were incubated with ConA-
Sepharose beads or control Sepharose beads for 1 h at 4
 
8
 
C. After five
washes, the bound proteins were solubilized with SDS sample buffer. Pro-
tein samples were analyzed by SDS-PAGE, and blots were probed with
anti-myc antibodies (1:50) and HRP-conjugated goat anti–mouse second-
ary antibodies (Jackson ImmunoResearch) to detect the presence of
TM–
 
b
 
-catenin 1-myc in the samples. To determine levels of endogenous
 
b
 
-catenin present in APC and ConA precipitates, we probed blots with
anti–
 
b
 
-catenin antibodies as described above.
 
Rabbit Reticulocyte Lysate Assays
 
RNAs encoding 
 
b
 
-catenin and 
 
Xenopus
 
 N-cadherin (Detrick et al., 1990)
were transcribed in vitro using a Message Machine kit (Ambion, Inc.). A
rabbit reticulocyte lysate was used with RNAs translated individually for
60 min at 30
 
8
 
C. The 
 
b
 
-catenin reactions were supplemented with [
 
35
 
S]me-
thionine and then centrifuged (4
 
8
 
C) after translation for 15 min. 
 
Xenopus
 
N-cadherin RNA was translated using nonradioactive methionine in the
presence of canine pancreatic microsomes (Promega Corp., Madison,
WI). To test 
 
b
 
-catenin binding to N-cadherin, 25-
 
m
 
l aliquots of transla-
tions of microsomes with or without N-cadherin were mixed with 15-
 
m
 
l re-
actions of 
 
b-catenin translations, followed by addition of ATP to 0.4 mM.
Samples were incubated for 3.5 h at (48C) on a rotator to allow binding to
membranes. Samples were centrifuged for 15 min at 20,000 g (48C) and
then pelleted microsomes were carefully rinsed with reticulocyte lysate
lacking labeled protein. Pellets and aliquots of the supernatant were di-
luted with SDS gel sample buffer.
To determine whether phosphorylated b-catenin would interact with
microsomes in the presence of N-cadherin, RNAs were translated as
described above except that nonradioactive methionine replaced the
[35S]methionine. 60 ml of microsome translations conducted in the pres-
ence or absence of N-cadherin RNA were mixed with 50 ml of translations
of precentrifuged b-catenin. Assay tubes were then supplemented with 50 mCi
of [g32P]ATP, and z0.1 U of recombinant Xenopus glycogen synthase ki-
nase-3 (Xgsk-3) where indicated. After 20 min at 308C to facilitate phos-
phorylation, samples were rotated for 3 h at 48C to allow binding to mi-
crosomes and then centrifuged for 20 min at 20,000 g. The supernatants
and pellets were subjected to immunoprecipitation with a rabbit poly-
clonal antibody to b-catenin, followed by separation on SDS 10% poly-
acrylamide gels and autoradiography.
Results
Intracellular Distribution and Signaling Activity of 
b-Catenin Localization Mutants
b-catenin is a multifunctional protein that is localized to
several intracellular compartments, including the plasma
membrane, cytosol, and nucleus (for review see Miller and
Moon, 1996). The localization of b-catenin to each of
these compartments is thought to reflect the interaction of
b-catenin with various protein partners and the different
functions of b-catenin in cell adhesion and signal transduc-
tion. Recent studies have suggested that the signaling
function of b-catenin may be linked to accumulation of
b-catenin–Lef/Tcf complexes in nuclei (Behrens et al., 1996;
Molenaar et al., 1996). Although these studies suggest that
the signaling function of b-catenin is carried out in the nu-
cleus, we sought to directly test where in the cell b-catenin
is required to have signaling activity. We therefore con-
structed a series of b-catenin localization mutants that
contain additional sequences that target the resulting fu-
sion proteins to a specific subcellular compartment (Fig. 1
A). Each fusion protein was tagged with GFP (S65T mu-
tant; Heim et al., 1995) so that its intracellular localization
could be easily determined by confocal microscopy. The
wild-type (WT)–b-catenin–GFP construct was prepared as
a control and was expected to mimic both the localization
and function of endogenous b-catenin in various subcellu-
lar compartments. NES–b-catenin–GFP is a mutant that
contains the nuclear exclusion sequence of rabbit pkI at
the NH2 terminus (Wen et al., 1994, 1995). This mutant
was expected to mimic the functions of cytosolic and mem-
brane-bound b-catenin and would help test the require-
ment of nuclear localization for the signaling function of
b-catenin. NLS–b-catenin–GFP is a mutant that contains
the nuclear localization signal of the SV-40 large T-antigen
(Kalderon et al., 1984; Lanford and Butel, 1984) fused to
the NH2 terminus of b-catenin. This protein was expected
to localize exclusively to nuclei and was produced to test
the requirement for either cytosolic or membrane-local-
ized b-catenin in signal transduction. Finally, TM–b-cate-
nin is a mutant that contains the signal sequence and trans-
membrane domain of Xenopus N-cadherin fused to the
NH2 terminus of b-catenin. This construct was produced
to restrict b-catenin to membranes and, similar to the
NES–b-catenin construct, would test whether nuclear lo-
calization is required for the signaling function of b-catenin.
To determine the intracellular localization of each mu-
tant construct, Xenopus animal cap cells expressing each
GFP-tagged form of b-catenin were examined by confocal
microscopy. WT–b-catenin–GFP accumulates at the plasma
membrane, in the cytosol, and in the nucleus (Fig. 2 A).The Journal of Cell Biology, Volume 139, 1997 232
This pattern is identical to that seen for endogenous
b-catenin in animal cap cells (Yost et al., 1996), demon-
strating that the GFP tag does not influence the subcellular
localization of the b-catenin fusion protein. NES–b-cate-
nin–GFP is found predominantly in the cytoplasm and at
the plasma membrane, although low levels of GFP fluores-
cence are detected in the nucleus (Fig. 2 B). The NLS–b-cate-
nin–GFP fusion protein is localized almost exclusively to
nuclei, although faint fluorescence is detected in associa-
tion with the plasma membrane (Fig. 2 C). TM–b-catenin–
GFP is localized to intracellular vesicles and organelles pre-
dictive of its association with the endoplasmic reticulum
and Golgi apparatus (Fig. 2 D). TM–b-catenin–GFP was
never detected in the nucleus.
The intracellular distribution observed for each localiza-
tion mutant of b-catenin matched our predictions and,
therefore, allowed us to test whether the signaling activity
of b-catenin is dependent on its subcellular localization.
The signaling activity of b-catenin can be assayed by de-
termining its ability to induce a secondary axis after over-
expression in ventral blastomeres (Funayama et al., 1995),
as also observed with other components of the Wnt-1 sig-
naling pathway (for review see Moon et al., 1997). There-
fore, synthetic RNAs encoding each localization mutant
were injected into the marginal zone of each ventral blas-
tomere at the four-cell stage, and embryos were scored at
stage 40 for the presence or absence of a secondary embry-
onic axis. Given the recent demonstration that b-catenin
interacts with members of the Lef/Tcf family of transcrip-
tion factors (Behrens et al., 1996; Molenaar et al., 1996),
we predicted that both the NES and TM mutants, which
do not accumulate in nuclei, would be inactive in the axis
duplication assay, whereas the WT and NLS mutants
would cause axis duplication. In contrast to these predic-
tions, we found that overexpression of any of the localiza-
tion mutants resulted in embryos with secondary axes (Ta-
ble I) suggesting that the translocation of ectopic b-catenin
into the nucleus may not be required for the establishment
of dorsal cell fates.
The Signaling Activity of the TM–b-Catenin Mutant
Is Suppressed by Overexpression of Cadherin
One interpretation of the axis duplication results is that
the signaling activity of b-catenin is independent of its lo-
calization in the cell, consistent with the observation that a
membrane-tethered form of plakoglobin is also able to in-
duce an axis duplication (Merriam et al., 1997). Another
possible interpretation, however, is that the ectopic b-cate-
nin competes with endogenous b-catenin for access to the
machinery that regulates steady-state levels of b-catenin.
This hypothetical competition could lead to the elevation
of endogenous b-catenin levels that could engage in sig-
naling activities. To distinguish between these possibilities,
we took advantage of the observation that overexpression
of C-cadherin can suppress the signaling activity of b-cate-
nin by anchoring b-catenin to the membrane (Fagotto et
al., 1996). Therefore, we prepared a deletion mutant of
TM–b-catenin that lacks the amino terminus, Arm repeats
10–13, and the carboxy terminus (Fig. 1 A, TM–b-catenin
1–9). This mutant lacks the region necessary for C-cad-
herin binding but retains the region required for APC
binding (Fagotto et al., 1996). The rationale for this exper-
iment is that if the TM–b-catenin 1–9 mutant is directly in-
volved in establishing dorsal cell fates, then overexpres-
sion of C-cadherin should not be able to suppress its
signaling activity. However, if the TM–b-catenin 1–9 mu-
tant is functioning indirectly by elevating a free, signaling
pool of endogenous b-catenin, overexpression of C-cad-
herin should be able to suppress axis duplication by se-
questering endogenous b-catenin to the plasma mem-
brane. Therefore, RNA encoding TM–b-catenin 1–9 was
injected into ventral blastomeres in the presence or ab-
sence of C-cadherin RNA, and embryos were scored at
stage 40 for duplication of the embryonic axes (Table II).
Overexpression of TM–b-catenin 1–9 in ventral blas-
tomeres resulted in the induction of secondary axes at very
high frequency (Table II). In contrast, coinjection of C-cad-
herin completely suppressed the ability of TM–b-catenin
1–9 to induce secondary axes. This result demonstrates
that the TM–b-catenin mutant lacks signaling activity, de-
fined as an ability to induce an ectopic embryonic axis, un-
Figure 1. Schematic representation of constructs used in this
study. (A) Diagrams depicting the structure of wild-type and lo-
calization mutant b-catenin proteins. Some constructs were
tagged at the COOH terminus with either GFP (S65T mutant;
Heim et al., 1995) or a c-myc epitope (Evan et al., 1985). Shad-
owed boxes represent the 13 Arm repeats with a nonrepeat se-
quence between repeats 10 and 11. Sequences directing b-catenin
to specific intracellular compartments were added to the NH2 ter-
minus of both wild-type and truncated forms of b-catenin. Wild-
type human plakoglobin possesses an overall structure identical
to that of b-catenin and is tagged at the NH2 terminus with a c-myc
epitope (Merriam et al., 1997). (B) Linear representation of wild-
type human APC protein showing conserved motifs, including
the oligomerization domain, Arm repeats, 15– and 20–amino acid
repeats, microtubule binding domain (MT binding), and discs
large binding domain (Dlg binding). The central portion of APC,
which is sufficient for b-catenin binding and downregulation
(Munemitsu et al., 1995), was tagged at the COOH terminus with
GFP (S65T mutant; Heim et al., 1995).Miller and Moon Activities of Localization Mutants of b-Catenin 233
der conditions (overexpression of C-cadherin) where en-
dogenous b-catenin is sequestered to the plasma membrane.
Overexpression of the TM–b-Catenin Mutant Results
in Stabilization of Endogenous b-Catenin
To test whether the overexpression of TM–b-catenin
causes a stabilization of endogenous b-catenin in the cyto-
sol and nucleus, we extracted protein from embryos in-
jected with control GFP RNA or TM–b-catenin RNA and
performed immunoblot analyses to determine the relative
levels of endogenous b-catenin in both total (T) and soluble
(S) protein fractions (Fig. 3). Soluble fractions represent
lysates that have been incubated with ConA-Sepharose
beads, which bind many membrane glycoproteins, including
all cadherins (Fagotto et al., 1996). Thus, b-catenin present
in the supernatant after incubation with ConA beads rep-
resents the soluble, non–cadherin-bound pool of b-catenin
in the cell. This procedure allowed us to estimate the rela-
tive distribution of endogenous b-catenin in total homoge-
nates (Fig. 3, T) and soluble, non–cadherin-bound pools
(Fig. 3, S). Protein samples were analyzed by SDS-PAGE,
and blots were probed with anti–b-catenin and anti–a-spec-
trin antibodies. We found that overexpression of either
TM–b-catenin 1-myc or TM–b-catenin 1–9 results in an
approximate twofold increase in total (T) and an approxi-
mate three- to fourfold increase in soluble (S) levels of en-
dogenous b-catenin after normalizing b-catenin to levels of
Figure 2. Localization of wild-
type and mutant b-catenin–GFP
proteins in animal cap cells. The
intracellular distribution of each
mutant was determined by confo-
cal microscopy (A–D). The WT–
b-catenin–GFP protein (A) is lo-
calized to the plasma membrane,
cytosol, and nucleus in a pattern
indistinguishable from that seen
for endogenous b-catenin protein
(Yost et al., 1996). NES–b-cate-
nin–GFP (B) is present at plasma
membrane and at high levels in
the cytoplasm. Low levels of fluo-
rescence are detected in the nu-
cleus, which likely reflects the fact
that the NES domain does not in-
hibit nuclear entry but instead
promotes the rapid export of
tagged proteins from the nucleus.
NLS–b-catenin–GFP (C) is pre-
dominantly found in the nucleus,
and very little fluorescence is ob-
served in the cytoplasm or in asso-
ciation with the plasma membrane.
The TM–b-catenin–GFP mutant
(D) localizes to intracellular vesi-
cles and organelles in apparent as-
sociation with the endoplasmic
reticulum and Golgi apparatus.
TM–b-catenin–GFP fluorescence
was never detected in the nucleus.
Table I. Frequency of Axis Duplication by b-Catenin 
Localization Mutants
Construct Percentage of embryos with axis duplication (n)
WT–b-catenin–GFP 98.2 (55)
NES–b-catenin–GFP 97.1 (69)
NLS–b-catenin–GFP 98.3 (59)
TM–b-catenin–GFP 96.8 (62)
Embryos were injected ventrally at the four-cell stage with 250 pg RNA encoding
each b-catenin protein, and axis duplication was scored at stage 40 by the presence of
a secondary dorsal axis.
Table II. C-cadherin Inhibits the Ability of TM–b-Catenin to 
Induce a Secondary Dorsal Axis
TM–b-catenin 1–9
TM–b-catenin 1–9 1
C-cadherin
Percentage of embryos with 
duplicated axis (n) 94.8 (77) 0 (77)
Embryos were injected ventrally at the four-cell stage with either 50 pg TM–b-catenin
1–9 RNA or a combination of 50 pg TM–b-catenin 1–9 RNA and 1.25 ng C-cadherin
RNA. Axis duplication was scored at stage 40 by the presence of a secondary dorsal
axis.The Journal of Cell Biology, Volume 139, 1997 234
a-spectrin (numbers below each lane represent relative
levels of b-catenin in TM–b-catenin–injected embryos
compared to GFP-injected controls). The ability of both
TM–b-catenin mutants to stabilize endogenous b-catenin
was confirmed in a second, independent experiment (data
not shown). Thus, overexpression of TM–b-catenin results
in the elevation of both total and soluble pools of endoge-
nous b-catenin.
Overexpression of the TM–b-Catenin Mutant Results in 
Accumulation of Endogenous b-Catenin in Nuclei
Given that the TM–b-catenin mutant appears to signal by
elevating a free, signaling pool of endogenous b-catenin,
we sought to determine whether overexpression of TM–
b-catenin results in the accumulation of endogenous b-cate-
nin in nuclei in a manner similar to that seen after inhibi-
tion of GSK-3 (Yost et al., 1996) and activation of Wnt
signaling (Larabell et al., 1997). Therefore, we overex-
pressed several mutant b-catenin constructs and examined
the distribution of endogenous b-catenin in animal caps by
confocal microscopy. Since our anti–b-catenin antibody
recognizes the NH2-terminal domain (Yost et al., 1996),
we used TM–b-catenin mutants that lack the NH2-termi-
nal domain to distinguish endogenous b-catenin protein
from ectopic b-catenin proteins. We found that overex-
pression of TM–b-catenin 1–9 resulted in the increased ac-
cumulation of endogenous b-catenin in nuclei (Fig. 4, A–F).
Specifically, after injection of TM–b-catenin we observed
that a subset of animal cap cells show elevated levels of en-
dogenous b-catenin in nuclei (Fig. 4, A and D, arrowheads).
Since a fluorescent lineage tracer (Oregon green dextran
[OGDx]; Fig. 4, B and E) was coinjected with the RNA, si-
multaneous analysis of cells possessing elevated nuclear
b-catenin and the lineage tracer (Fig. 4, C and F) reveals a
direct correspondence between the presence of TM–b-cate-
nin and accumulation of endogenous b-catenin in the nu-
cleus. Neighboring cells not receiving TM–b-catenin 1–9
RNA do not show high levels of endogenous b-catenin in
the nucleus (Fig. 4, A, C, D, and F, arrows). In addition, a
small percentage of cells (z10%) that received TM–b-cate-
nin RNA also does not show high levels of endogenous
b-catenin in the nucleus. The reason for this result is un-
clear, but it may simply represent differences in the respon-
siveness of individual cells to TM–b-catenin expression,
variations in the levels of TM–b-catenin RNA received by
each cell, or cell cycle differences in the levels of endoge-
nous b-catenin in the nucleus. The effect of overexpres-
sion of TM–b-catenin on the localization of endogenous
b-catenin was confirmed in four separate experiments in
which z15 animal cap explants were analyzed. Identical
results to those presented in Fig. 4 were also obtained with
a TM–b-catenin DN mutant, which only lacks the amino-
terminal domain (data not shown). In contrast to the effect
of TM–b-catenin expression on nuclear b-catenin levels,
injection of a control RNA encoding b-catenin DN-9 (Fig.
1 A), a mutant that lacks the NH2-terminal domain and
Arm repeats 1–9 and is not active in the axis duplication
assay (data not shown), does not affect levels of endoge-
nous b-catenin in the nucleus (Fig. 4, G–I). Thus, ectopic
expression of b-catenin causes an unsuspected accumula-
tion of endogenous b-catenin in nuclei, similar to overex-
pression of activators of the Wnt pathway (Schneider et
al., 1996; Yost et al., 1996; Larabell et al., 1997). The sim-
plest explanation is that ectopic b-catenin present in the cy-
toplasm or even at membranes competes with endogenous
b-catenin for access to the degradative machinery, result-
ing in the stabilization and accumulation of endogenous
b-catenin in the nucleus, a hypothesis tested below.
TM–b-Catenin Competes with Endogenous 
b-Catenin for Interactions With Endogenous 
APC and a Cadherin Fraction
Both APC and cadherin are potential regulators of the sig-
naling function of b-catenin (for review see Miller and
Moon, 1996) and, therefore, are candidates to play a role
in the stabilization of endogenous b-catenin after overex-
pression of TM–b-catenin. To test whether TM–b-catenin
binds endogenous APC and cadherin, protein lysates ex-
tracted from embryos injected with TM–b-catenin 1-myc
RNA were subjected to immunoprecipitation with anti-
APC antibodies (Fig. 5 A, APC-IP) and ConA precipita-
tion (Fig. 5 A, ConA, represents cadherin-bound b-cate-
nin). The association of TM–b-catenin 1-myc with APC
and the ConA fraction containing cadherins was then as-
sayed by immunoblotting with anti-myc antibodies. We
found that TM–b-catenin 1-myc coimmunoprecipitated
with APC (Fig. 5 A, APC-IP) and was also present in the
ConA precipitates that contain cadherins (Fig. 5 A,
ConA). TM–b-catenin 1-myc is not detected in lysates in-
cubated with beads alone, demonstrating the specificity of
both precipitations (Fig. 5 A, beads). Thus, ectopic TM–
b-catenin interacts with endogenous APC and is present in
a fraction that contains cadherins. Given this result, we
Figure 3. Overexpression of TM–b-catenin results in the stabili-
zation of endogenous b-catenin. Injection of 1.25 ng of control
RNA (GFP), TM–b-catenin 1-myc RNA, or TM–b-catenin 1–9
RNA demonstrates overexpression of both forms of TM–b-cate-
nin results in an increase in the steady-state levels of endogenous
b-catenin in both total (T) and soluble (S, non–cadherin-bound)
lysates. In this experiment, two-cell stage embryos were injected
with RNA at four sites, followed by protein extraction at stage 7.
To control for protein loading, all endogenous b-catenin bands
were normalized to a-spectrin signals from the same Western
blot. Numbers below each lane represent the relative level of en-
dogenous b-catenin in each sample (control levels were assigned
a value of 1.0). Molecular mass markers indicated are 113 and 75 kD.Miller and Moon Activities of Localization Mutants of b-Catenin 235
asked whether the binding of TM–b-catenin to APC and
its association with a fraction that contains cadherins re-
duces the levels of endogenous b-catenin associated with
APC and the cadherin fraction. Protein extracts from em-
bryos injected with either a control RNA or TM–b-catenin
1-myc were subjected to immunoprecipitation with anti-
APC antibodies (Fig. 5 B) or ConA precipitation (Fig. 5
C), and the levels of endogenous b-catenin were subse-
quently determined by immunoblotting with anti–b-cate-
nin antibodies. We observed that overexpression of TM–
b-catenin 1-myc results in a decrease in the steady-state
levels of endogenous b-catenin associated with APC (Fig.
5 B) and a cadherin fraction (Fig. 5 C). The levels of en-
dogenous b-catenin that coimmunoprecipitate with APC
after overexpression of TM–b-catenin 1-myc were found
to decrease approximately threefold relative to control
levels in two experiments and decreased approximately
1.2-fold in a third experiment. Levels of endogenous b-cate-
Figure 4. Overexpression of TM–b-catenin results in the accumulation of endogenous b-catenin in the nucleus. RNA encoding TM–
b-catenin 1–9 (A–F) was coinjected with Oregon green dextran (OGDx; B, E, and H) as a lineage tracer to determine the effect of TM–
b-catenin overexpression on the distribution of endogenous b-catenin (A, C, D, and F). Merged images (C and F) demonstrate that cells
overexpressing TM–b-catenin 1–9 possess high levels of endogenous b-catenin in nuclei (arrowheads) in contrast to that observed in
nonexpressing cells (arrows). Overexpression of DN-9 b-catenin (G–I), that does not promote axis duplication, does not affect the levels
of endogenous b-catenin in the nucleus (G and I; arrowheads mark nuclei of cells expressing the DN-9 mutant and arrows mark nuclei of
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nin associated with a cadherin fraction after overexpression
of TM–b-catenin 1-myc were found to decrease to z0.6 of
control levels in each of three experiments. These data
suggest that the binding of ectopic b-catenin to both APC
and cadherin results in a decrease in the binding of endog-
enous b-catenin to each protein and the accumulation of a
free, signaling pool of endogenous b-catenin in the cell.
Overexpression of the TM–b-Catenin Mutant Results
in the Relocalization of APC
To further examine the ability of TM–b-catenin mutants
to compete for interactions with APC, a protein thought to
be involved in regulating the stability of b-catenin in cells
(Munemitsu et al., 1995; Papkoff et al., 1996), we investi-
gated whether overexpression of TM–b-catenin can affect
the localization of APC in the cell. We attempted to examine
the effect of TM–b-catenin expression on the localization
of endogenous APC but were unsuccessful in obtaining
any specific staining in animal cap cells using the anti-APC
antibodies from two different sources (Rubinfeld et al.,
1993; Näthke et al., 1996). Therefore, to perform this ex-
periment we constructed an APC deletion mutant that
contains the b-catenin–binding sites that are necessary and
sufficient to promote the rapid degradation of b-catenin in
cultured cells (Munemitsu et al., 1995) and fused this mu-
tant to GFP to facilitate visualization of the fusion protein
by confocal microscopy (Fig. 1 B, APC–GFP). Analysis of
cells expressing APC–GFP demonstrated that this protein
is distributed uniformly throughout the cytoplasm and is
absent from the nucleus (Fig. 6 A). Coexpression of TM–
b-catenin 1–9 resulted in the dramatic redistribution of
APC–GFP (Fig. 6 B) to a pattern similar to that seen for
TM–b-catenin GFP (see Fig. 2 D). Overexpression of
TM–b-catenin 1–9 did not affect the localization of control
GFP protein (data not shown), demonstrating the specific-
ity of its affect on the distribution of APC–GFP. Experi-
ments using an myc-tagged TM–b-catenin construct (Fig. 1
A, TM–b-catenin 1-myc) further demonstrate that the dis-
tribution of the membrane-tethered b-catenin protein
(Fig. 6 D) and that of APC–GFP (Fig. 6 C) completely
overlap (yellow represents overlapping staining; Fig. 6 E).
These data strongly suggest that ectopic b-catenin mutants
interact with APC, a component of the degradative ma-
chinery. Such interactions may reduce the ability of endog-
enous  b-catenin to interact with endogenous or ectopic
APC, resulting in its stabilization and increased availabil-
ity for signaling.
Overexpression of Plakoglobin Results
in the Accumulation of Endogenous b-Catenin
in the Nucleus and the Relocalization
of APC–GFP in the Cytoplasm
Plakoglobin is closely related to b-catenin, and like b-cate-
nin, ectopic plakoglobin accumulates in nuclei and can in-
duce a secondary axis when overexpressed in Xenopus
embryos (Karnovsky and Klymkowsky, 1995). Given that
plakoglobin interacts with many of the same protein part-
ners as b-catenin, we hypothesized that ectopic plakoglo-
bin may compete with endogenous b-catenin for interac-
tions with these protein partners resulting in the formation
of a free, signaling pool of endogenous b-catenin in a man-
ner similar to that seen after overexpression of the mem-
brane-tethered b-catenin. To test this possibility, we inves-
tigated whether overexpression of plakoglobin (Fig. 1 A,
h-plakoglobin) alters the distribution of endogenous b-cate-
nin in animal cap cells. We injected RNA encoding myc-
tagged plakoglobin into the animal pole of blastomeres at
the four-cell stage and examined the distribution of both
endogenous b-catenin (Fig. 7, A and C) and ectopic plako-
globin (Fig. 7, B and C) in animal cap cells. Ectopic myc-
tagged plakoglobin accumulated in the cytoplasm of ani-
mal cap cells but was not seen in nuclei (Fig. 7, B and C).
Visualization of endogenous b-catenin in the same cells
Figure 5. Ectopic TM–b-catenin competes with endogenous
b-catenin for binding to endogenous APC and a cadherin frac-
tion. (A) Protein extracted from embryos injected with 1.25 ng of
TM–b-catenin 1-myc RNA was subjected to APC immunoprecip-
itation (APC-IP) or ConA precipitation (ConA, represents cad-
herin-bound fraction) followed by immunoblotting with anti-myc
antibodies. Control lysates were incubated with beads alone
(beads). These experiments show that TM–b-catenin 1-myc binds
endogenous APC and is present in ConA-bound fractions, indi-
cating an association with cadherin. (B) To determine the effect
of overexpression of TM–b-catenin 1-myc on the levels of endog-
enous b-catenin associated with APC, protein extracts from con-
trol embryos or embryos injected with 1.25 ng TM–b-catenin 1-myc
were subjected to immunoprecipitation with anti-APC antibodies
followed by immunoblotting with anti–b-catenin antibodies.
These analyses show that overexpression of TM–b-catenin 1-myc
causes a decrease relative to controls in the levels of endogenous
b-catenin associated with APC. (Relative levels of endogenous
b-catenin are shown below each lane with controls set to 1.0.) (C)
Changes in the levels of endogenous b-catenin associated with a
cadherin fraction were examined by preparing ConA precipitates
from protein extracts prepared from control or TM–b-catenin
1-myc RNA–injected embryos followed by immunoblotting with
anti–b-catenin antibodies. The levels of endogenous b-catenin
present in ConA fractions decreased to 0.6 of control levels, sug-
gesting that ectopic TM–b-catenin competes with endogenous
b-catenin for binding to cadherin. (Relative levels of endogenous
b-catenin are shown below each lane.) Molecular mass markers
indicated in A are 198, 113, and 75 kD and those indicated in B
and C are 113 and 75 kD.Miller and Moon Activities of Localization Mutants of b-Catenin 237
(Fig. 7, A and C) revealed that elevated levels of endoge-
nous b-catenin were present in nuclei of cells that pos-
sessed ectopic plakoglobin (Fig. 7, A and C, arrowheads),
whereas no such elevation was apparent in cells that do
not possess ectopic plakoglobin (Fig. 7, A and C, arrows).
Therefore, overexpression of plakoglobin results in the ac-
cumulation of endogenous b-catenin in nuclei. These data
are consistent with the idea that the observed signaling ac-
tivity of plakoglobin may be attributable, at least in part,
to the formation of a free, signaling pool of endogenous
b-catenin that accumulates in the nucleus to affect target
gene expression. Importantly, we observe the accumula-
tion of endogenous b-catenin in the nucleus at levels of in-
jected plakoglobin RNA (1–2 ng) that are less than was
used by Karnovsky and Klymkowsky (1995) to establish
the axis-inducing activity of plakoglobin.
The effect of overexpression of plakoglobin on the in-
tracellular distribution of endogenous b-catenin prompted
us to ask whether ectopic plakoglobin can sequester APC
as we had shown for membrane-tethered b-catenin. Coex-
pression of myc-tagged plakoglobin and APC–GFP resulted
in a dramatic change in the localization of APC–GFP
(compare Fig. 7 F to control localization shown in Fig. 7
D) to a pattern identical to that of plakoglobin (Fig. 7 G).
Superimposing the individual images confirms the colocal-
ization of plakoglobin and APC–GFP in cells (arrows mark
overlapping staining that appears yellow in Fig. 7 H).
These data strongly suggest that ectopic plakoglobin inter-
acts with APC, an important regulator of b-catenin stabil-
ity. This situation may result in competition between ec-
topic plakoglobin and endogenous b-catenin for binding
to APC, leading to an increase in a free, signaling pool of
b-catenin that accumulates in the nucleus.
Different Phosphorylation Isoforms of b-Catenin 
Compete for Interactions With Cadherin
The above experiments suggest that ectopic b-catenin
competes with endogenous b-catenin, leading to the accu-
mulation of endogenous b-catenin in nuclei. This result
raises the question of whether competition exists normally
between endogenous pools of b-catenin in the cell. We hy-
pothesized that besides promoting b-catenin/Armadillo
degradation (Peifer et al., 1994; Yost et al., 1996), GSK-3
might also modulate the interaction of b-catenin with cad-
herins at the plasma membrane. Consistent with this idea,
Figure 6. Overexpression of TM–b-catenin results in the redistribution of APC–GFP in animal cap cells. Intracellular distribution of
APC–GFP in the absence (A) or presence (B) of TM–b-catenin 1–9. Coexpression of TM–b-catenin 1–9 causes a dramatic redistribu-
tion of APC–GFP from a diffuse cytosolic pattern (A) to an apparent association with the secretory apparatus (B). The interaction be-
tween TM–b-catenin and APC–GFP was further demonstrated by coexpressing an myc-tagged TM–b-catenin mutant (TM–b-catenin
1-myc) with APC–GFP and examining the pattern of each protein in animal cap cells. Both TM–b-catenin 1-myc (C) and APC–GFP
(D) proteins display an overlapping intracellular distribution seen in the merged image (E; arrows in C–E).The Journal of Cell Biology, Volume 139, 1997 238
both tyrosine- and serine/threonine-phosphorylated forms
of Armadillo preferentially associate with membrane frac-
tions compared to soluble, cytosolic fractions in Drosoph-
ila embryos (Peifer et al., 1994). To address this hypothesis,
we investigated whether phosphorylation of b-catenin by
Xgsk-3 changes the association of b-catenin with N-cadherin
in vitro. In control experiments, we found that 35S-labeled
b-catenin specifically bound to microsomal membranes
containing N-cadherin (compare Fig. 8 A, lanes 2 and 3) in
reticulocyte lysates. In these experiments, we also deter-
mined that the unbound b-catenin present in the superna-
tant (Fig. 8 A, lane 1) reflected a 12–18-fold excess relative
to that bound to the N-cadherin microsomes in the pellet
(Fig. 8 A, lane 2).
We then exploited the excess of b-catenin in the super-
natant relative to that bound to cadherin in the reticulo-
cyte lysate binding assay to directly test whether the phos-
phorylation of b-catenin by Xgsk-3 altered its ability to
bind microsomes expressing N-cadherin. The assays were
conducted in the presence of [g32P]ATP, which was added
to the reticulocyte lysate to facilitate detection of phos-
phoproteins, and all samples were immunoprecipitated
with an anti–b-catenin antibody to specifically monitor
phosphorylated  b-catenin. When b-catenin RNA is cotrans-
lated with Xgsk-3 RNA, then bound to microsomes ex-
pressing N-cadherin, most of the phosphorylated b-cate-
nin is associated with the microsomal pellet (Fig. 8 B, lane
5) rather than the supernatant (Fig. 8 B, lane 1), which
contains the majority of the total b-catenin in this assay
(Fig. 8 A). The same results were obtained when recombi-
Figure 7. Overexpression of plakoglobin causes the accumulation of endogenous b-catenin in the nucleus and the redistribution of
APC–GFP. Human plakoglobin was overexpressed in animal cap cells, and the distribution of both endogenous b-catenin (A and C)
and myc-tagged plakoglobin (B and C) was determined by confocal microscopy. Cells expressing ectopic plakoglobin possess high levels
of endogenous b-catenin in the nucleus (arrowheads in A and C) when compared to cells not expressing ectopic plakoglobin (arrows in
A and C). Overexpression of plakoglobin also results in the redistribution of APC–GFP within the cell to sites of plakoglobin accumula-
tion. The localization of APC–GFP (D) and ectopic plakoglobin (E) in the absence of other RNAs demonstrates the different localiza-
tion patterns of the two ectopic proteins. Coinjecting APC–GFP and plakoglobin, however, results in the redistribution of APC–GFP
(F) to a pattern indistinguishable from that seen for ectopic plakoglobin (G). Overlapping APC–GFP (F) and plakoglobin (G) staining
appears as yellow staining in the merged image (H). Arrows mark examples of APC–GFP and plakoglobin colocalization.Miller and Moon Activities of Localization Mutants of b-Catenin 239
nant Xgsk-3 protein was added to translations of b-catenin
(Fig. 8 B, lane 6, pellet, and lane 2, supernatant). The pref-
erential association of phosphorylated b-catenin with N-cad-
herin containing microsomes is a specific interaction since
the amount of phosphorylated b-catenin in the microso-
mal pellet was reduced and the amount in the supernatant
increased, by omission of N-cadherin from the assay (Fig.
8 B, lane 7, pellet, and lane 3, supernatant). Omission of
Xgsk-3 from the assay (Fig. 8 B, lane 8, pellet, and lane 4,
supernatant) also results in a decrease in the N-cadherin–
bound b-catenin relative to that present in the superna-
tant, demonstrating that phosphorylation of b-catenin by
Xgsk-3, and not kinases that may be present in reticulo-
cyte lysates, is responsible for the observed increase in the
association of phosphorylated b-catenin with N-cadherin.
Since phosphorylated b-catenin is primarily associated
with the microsomal membranes in a cadherin-dependent
manner under conditions where the majority of b-catenin
remains in the postmicrosomal supernatant (Fig. 8 A),
these data strongly suggest that phosphorylation of b-cate-
nin by Xgsk-3 enhances its association with the cytoplas-
mic domain of cadherins. In Fig. 8 and in independent ex-
periments, we observed that the total level of phosphorylated
b-catenin (estimated by the combined levels in both the
supernatant and pellet lanes) was somewhat greater in the
presence relative to the absence of N-cadherin (data not
shown). This raises the questions of whether the phosphor-
ylation of b-catenin occurs before, during, or after associa-
tion with cadherins and whether the interaction of b-catenin
with cadherin facilitates the process of phosphorylation or
decreases the degradation of the phosphorylated b-catenin.
In independent experiments, we asked if recombinant
b-catenin, phosphorylated in vitro by recombinant Xgsk-3,
preferentially associates with N-cadherin–GST fusion pro-
tein bound to glutathione beads. Consistent with the con-
clusions reported here, we find that under conditions
where the majority of the b-catenin is not phosphorylated
and is not bound to the cadherin beads (i.e., b-catenin is
present in excess) the phosphorylated form of b-catenin is
preferentially bound to the cadherin beads (Torres, M.,
and R.T. Moon, unpublished data).
Discussion
The function of b-catenin in specifying dorsal cell fate in
Xenopus embryos may be dependent on interactions with
Lef/Tcf transcription factors and the accumulation of b-cate-
nin–Lef/Tcf complexes in the nucleus, where they posi-
tively regulate expression of dorsal-specific genes (for review
see Moon et al., 1997). In support of this hypothesis, b-cate-
nin is detected in nuclei of dorsal but not ventral blas-
Figure 8. Phosphorylation of b-catenin by Xgsk-3 enhances association with N-cadherin in vitro. (A) b-catenin was translated in vitro in
the presence of [35S]methionine and, in separate reactions, microsomal membranes were incubated in rabbit reticulocyte lysate with un-
labeled methionine in the presence or absence of N-cadherin RNA. The b-catenin reactions and microsome reactions were then mixed,
and the samples were incubated to allow binding of b-catenin to the microsomal membranes. The samples were then centrifuged to gen-
erate microsomal pellets and supernatants. Lane 1, 35S–b-catenin present in the supernatant after centrifugation. Adjusting for volumes,
these lanes contain 40% of the total supernatant. Lane 2, 35S–b-catenin associated with the pelleted microsomes containing N-cadherin.
Lane 3, 35S–b-catenin associated with control microsomes. The data show that a small percentage of the total 35S-labeled b-catenin binds
microsomal membranes in a cadherin-dependent manner (compare lanes 1 and 2). (B) b-catenin and Xgsk-3 RNAs, as well as microso-
mal membranes with or without N-cadherin RNAs, were translated in vitro with nonradioactive methionine and then incubated with or
without recombinant Xgsk-3 protein in the presence of [g32P]ATP. After centrifugation, the samples were immunoprecipitated with an
anti–b-catenin antibody. Lanes 1 and 5, immunoprecipitation of b-catenin from the supernatant (lane 1) and microsome/N-cadherin pel-
let (lane 5) after cotranslation with Xgsk-3 RNA demonstrates that most of the phosphorylated b-catenin associates with the microso-
mal pellet. Lanes 2 and 6, immunoprecipitation of b-catenin from the supernatant (lane 2) and pellet (lane 6) of b-catenin translations
incubated with recombinant Xgsk-3 protein confirms the conclusion of lanes 1 and 5. Lanes 3 and 7, omission of N-cadherin RNA dem-
onstrates that most phosphorylated b-catenin is immunoprecipitated from the supernatant (lane 3) and not the microsomal pellet lacking
N-cadherin (lane 7). Lanes 4 and 8, omission of exogenous Xgsk-3 protein and RNA demonstrates basal phosphorylation of b-catenin
by kinases present in the lysate, that is substantially lower than in samples supplemented with Xgsk-3, and this phosphorylated b-catenin
accumulates primarily in the supernatant (lane 4) rather than the pellet (lane 8), even though the microsomes contained N-cadherin.The Journal of Cell Biology, Volume 139, 1997 240
tomeres at the 16–32-cell stages of Xenopus (Larabell et
al., 1997) and after zygotic transcription has commenced at
the late blastula stage (Schneider et al., 1996). Moreover,
several recent studies have demonstrated that both b-cate-
nin and Armadillo can function as a transcriptional activa-
tor when complexed to Lef/Tcf transcription factors (Mo-
lenaar et al., 1996; Korinek et al., 1997; Morin et al., 1997;
van de Wetering et al., 1997). Taken together, these data
have led to the hypothesis that the signaling function of
b-catenin in establishing the dorsal axis in Xenopus em-
bryos is dependent on its nuclear localization. Although
many lines of evidence support this idea, several observa-
tions raise questions regarding this proposed model of
b-catenin signaling. Overexpression of b-catenin increases
gap junction permeability in the absence of transcription
(Guger and Gumbiner, 1995), suggesting it is modulating
intercellular communication in a manner independent of
de novo transcription. In addition, overexpression of a
membrane-tethered form of plakoglobin that is unable to
enter nuclei results in the induction of an ectopic dorsal
axis (Merriam et al., 1997), suggesting that the nuclear ac-
cumulation of endogenous b-catenin is not required to in-
duce the expression of dorsal-specific genes. Given these
discrepancies in the proposed model of how b-catenin
functions to establish dorsal cell fate, we have directly ex-
amined this issue and conclude that the signaling function
of b-catenin in axis specification is dependent on its local-
ization to the nucleus. Our studies also present a clear cau-
tionary note to all studies in which mutant proteins are
overexpressed in a wild-type background, as we show that
an unsuspected competition exists between ectopic and
endogenous proteins, resulting in functional activation of
the endogenous protein.
Is Nuclear b-Catenin Required for the Induction of 
Dorsal Cell Fate?
We targeted ectopic forms of b-catenin to membranes, the
cytoplasm, or the nucleus to test whether the accumulation
of b-catenin in nuclei is required for its role in specifying
the dorso–ventral axis in Xenopus embryos. We show that
all of the localization mutants tested are active in inducing
an ectopic axis, suggesting at first glance that the signaling
activity of ectopically expressed b-catenin is not depen-
dent on its localization to a specific subcellular compart-
ment. The axis-inducing activity of the TM–b-catenin mu-
tant was particularly perplexing given the proposed role of
nuclear b-catenin–Lef/Tcf complexes (Behrens et al., 1996;
Huber et al., 1996; Molenaar et al., 1996; Brunner et al.,
1997; Korinek et al., 1997; Morin et al., 1997; Riese et al.,
1997; van de Wetering et al., 1997). Therefore, we exam-
ined the mechanism underlying the signaling activity of
the membrane-tethered b-catenin and found that it acts
indirectly to specify dorsal cell fate by elevating the
steady-state levels of endogenous b-catenin, resulting in
the accumulation of a signaling pool of b-catenin in the
nucleus. Several lines of evidence support this conclusion:
(a) Overexpression of C-cadherin completely blocks the
ability of the TM–b-catenin 1–9 to induce an ectopic axis
(Table II) despite the fact that the presence of Arm re-
peats 1–9 is not sufficient for C-cadherin binding (Fagotto
et al., 1996). This result suggests that overexpression of
C-cadherin suppresses the axis-inducing activity of TM–
b-catenin 1–9 by sequestering endogenous b-catenin to the
plasma membrane where it is unable to signal. (b) Overex-
pression of various TM–b-catenin mutants results in an ap-
proximate three- to fourfold increase in the steady-state
levels of endogenous b-catenin in non–cadherin-bound
fractions (Fig. 3). This increase in the levels of soluble
b-catenin is manifest by the accumulation of endogenous
b-catenin in the nucleus (Fig. 4).
The mechanism by which overexpression of TM–b-cate-
nin causes the observed stabilization of endogenous b-cate-
nin may be the result of competition between ectopic and
endogenous b-catenin for binding to various protein part-
ners, including APC and cadherin. Both APC and cad-
herin have been implicated in regulating the signaling ac-
tivity of b-catenin and Armadillo (Munemitsu et al., 1995;
Cox et al., 1996; Fagotto et al., 1996; Papkoff et al., 1996;
Sanson et al., 1996; Korinek et al., 1997; Morin et al., 1997;
Rubinfeld et al., 1997) and, therefore, are candidates to
play a role in the stabilization of endogenous b-catenin af-
ter overexpression of TM–b-catenin. We show that ectopic
TM–b-catenin 1-myc protein interacts with endogenous
APC and with a cell fraction that contains cadherin and
that these interactions result in a decrease in the levels of
endogenous b-catenin associated with APC and cadherin
(Fig. 5). Moreover, overexpression of various TM–b-cate-
nin mutants dramatically alters the subcellular distribution
of ectopic APC (Fig. 6). This interaction with APC is
likely to be the most important factor in predicting the
ability of ectopic b-catenin to stabilize endogenous b-cate-
nin and induce dorsal cell fate. Previous studies have
shown that the ability of various b-catenin deletion mu-
tants to induce a secondary axis coincides with the ability
of each of these mutants to bind APC, while several of
these active mutants do not bind C-cadherin (Fagotto et
al., 1996). Together, these results are consistent with the
idea that the ectopic b-catenin competes with endogenous
b-catenin for binding to various protein partners, and in
particular APC. As APC is then unavailable for interac-
tions with endogenous b-catenin to promote its degrada-
tion, endogenous b-catenin accumulates in the cell and is
available for signaling.
The data presented here, taken together with evidence
that b-catenin interacts with Lef/Tcf transcription factors
(Behrens et al., 1996; Huber et al., 1996; Korinek et al.,
1997; Molenaar et al., 1996; Morin et al., 1997; Rubinfeld
et al., 1997; van de Wetering et al., 1997) and that endoge-
nous  b-catenin accumulates in nuclei of dorsal but not
ventral blastomeres of cleavage stage Xenopus embryos
(Larabell et al., 1997), strongly argue that the signaling ac-
tivity of b-catenin is dependent on its translocation into
the nucleus. In the nucleus, it is likely that Lef/Tcf bind to
the promoters of specific genes, and b-catenin interacts
with these promoters indirectly through its binding to Lef/
Tcf, resulting in altered DNA bending and modulation of
gene expression (Behrens et al., 1996). A likely target gene
of  b-catenin–Lef/Tcf complexes is the dorsal regulatory
gene siamois, whose expression is induced in response to
Wnt (Carnac et al., 1996; Yang-Snyder et al., 1996) and
b-catenin (Brannon and Kimelman, 1996; Brannon et al.,
1997).
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b-catenin mediates its signaling activity through interac-
tions with Lef/Tcf transcription factors, one may question
the importance of our demonstrating that nuclear accumu-
lation is necessary for the signaling activity of b-catenin. A
recent study by Merriam et al. (1997), however, demon-
strates that overexpression of a membrane-tethered pla-
koglobin mutant in Xenopus embryos results in the induc-
tion of an ectopic secondary axis. In contrast to our
conclusion regarding the function of TM–b-catenin, these
authors argue that the membrane-tethered plakoglobin in-
duces an ectopic dorsal axis by anchoring in the cytoplasm
a negative regulator of dorsal cell fate, hypothesized to be
XTcf-3 or a related factor, thereby blocking its inhibitory
function in the nucleus (Merriam et al., 1997). This inter-
pretation suggests that the result of Wnt signaling through
b-catenin or its ortholog plakoglobin is to inactivate an in-
hibitor of dorsal cell fate instead of a model where b-cate-
nin or plakoglobin functions in concert with Lef/Tcf tran-
scription factors to activate downstream target genes. Our
data are not consistent with the hypothesis of Merriam and
colleagues since we find that ectopic membrane-tethered
b-catenin, and by extension membrane-tethered plakoglo-
bin, function indirectly by elevating levels of endogenous
b-catenin in the cell. Similarly, we find that overexpression
of plakoglobin in Xenopus animal cap cells results in the
accumulation of endogenous b-catenin in the nucleus (Fig.
7) and that ectopic plakoglobin alters the distribution of
APC (Fig. 7), a regulator of b-catenin stability and b-cate-
nin–Lef/Tcf transcriptional activity (Munemitsu et al., 1995;
Papkoff et al., 1996; Hayashi et al., 1997; Korinek et al., 1997;
Morin et al., 1997). These data are most consistent with
the idea that ectopic plakoglobin saturates available APC-
binding sites, reducing the interaction of endogenous b-cate-
nin with APC, resulting in the stabilization of endogenous
b-catenin. Finally, we have found that TM–b-catenin does
not sequester XTcf-3, a potential regulator of dorsal-spe-
cific gene expression (Molenaar et al., 1996), in the cytoplasm
(data not shown). Thus, it seems unlikely that the related
form of membrane-tethered plakoglobin (Merriam et al.,
1997) would be active in axis induction by anchoring XTcf-3
or a related inhibitory factor to the plasma membrane.
Our data, however, do not rule out the possibility that
XTcf-3 normally acts as a transcriptional repressor when
bound to DNA on its own and that the binding of b-cate-
nin to XTcf-3 relieves this inhibition and instead promotes
transcription (Brannon et al., 1997). In summary, we sug-
gest that gain-of-function assays with plakoglobin are diffi-
cult to interpret because of the unanticipated effects on
endogenous b-catenin and APC described above. These
data taken together with the recent observation that deple-
tion of plakoglobin transcripts in early Xenopus embryos
does not inhibit the development of dorsal cell fates (Kofron
et al., 1997) suggest that plakoglobin is not a necessary con-
tributor to the signaling events involved in axis specification.
Implications of Competition between Ectopic
and Endogenous b-Catenin on Interpretations of 
Overexpression Studies in Xenopus Embryos
Our analyses of the function of TM–b-catenin raise a very
important caveat of overexpression analyses in Xenopus
embryos. We demonstrate that overexpression of TM–
b-catenin causes the elevation of a free, signaling pool of
endogenous b-catenin, and it is this endogenous pool that
is active in inducing an ectopic dorsal axis. Given this re-
sult, we hypothesize that the signaling activity of various
b-catenin mutants (Fagotto et al., 1996) or plakoglobin
mutants (Merriam et al., 1997) may be indirect, function-
ing by elevating levels of endogenous b-catenin in the cell
(Fig. 9). In fact, a discrepancy exists in the literature re-
garding the signaling activity of various b-catenin mutants
(Funayama et al., 1995; Fagotto et al., 1996) and similar
mutants in Armadillo (Orsulic and Peifer, 1996), the
Drosophila homologue of b-catenin. For example, a mu-
tant form of b-catenin lacking both the amino and car-
boxyl terminus induces a secondary dorsal axis when over-
expressed in Xenopus embryos (Funayama et al., 1995),
yet a similar mutant form of Armadillo is unable to trans-
duce the Wingless signal in Drosophila embryos (Peifer
and Wieschaus 1990; Orsulic and Peifer 1996). Moreover,
a recent study has demonstrated that the carboxy-terminal
domain of b-catenin and Armadillo constitutes a transacti-
vation domain that is required for Lef/Tcf-dependent tran-
scriptional activation (van de Wetering et al., 1997). Al-
though  b-catenin and Armadillo possess very similar
functional domains, it remains possible that this disparity
in the signaling activity of various b-catenin and Arma-
dillo mutants may be an actual difference between the
functional domains required for this activity. On the other
Figure 9. Model of the Wnt signaling pathway showing competi-
tion between endogenous and ectopic b-catenin for interactions
with several protein partners, including cadherin, APC, and Lef/
Tcf. Overexpression of various b-catenin mutants that possess
the ability to interact with APC (TM–b-catenin is shown) is pre-
dicted to increase the stability of endogenous b-catenin. The ac-
cumulation of endogenous b-catenin via activation of the Wnt
pathway or expression of ectopic b-catenin both result in the in-
crease of “free” b-catenin capable of interacting with members of
the Lef/Tcf family of transcription factors. This b-catenin tran-
scription factor complex translocates into the nucleus, where it
regulates the expression of target genes responsible for establish-
ing dorsal cell fate. Furthermore, phosphorylation of b-catenin by
XGSK-3 may not only regulate b-catenin stability but may also
result in competition between phosphorylated and nonphosphor-
ylated b-catenin isoforms for binding to the cytoplasmic domain
of cadherin.The Journal of Cell Biology, Volume 139, 1997 242
hand, this difference could be resolved by arguing that ec-
topically expressed b-catenin acts indirectly by competing
with endogenous b-catenin for interactions with APC, a
potential component of the degradative machinery. This
competition would result in the stabilization of a free, sig-
naling pool of endogenous b-catenin. In fact, examination
of the published data regarding the axis-inducing activity
of various b-catenin mutants shows that the ability of a
given ectopically expressed b-catenin mutant to induce
dorsal cell fate corresponds with its ability to bind APC
(Funayama et al., 1995; Fagotto et al., 1996). This conclu-
sion calls into question the interpretation of many b-cate-
nin overexpression studies performed in Xenopus embryos
and underscores the importance of determining the effects
of overexpression on the endogenous protein and protein
partners with which the overexpressed protein may interact.
Implications of Competition between
Different Phosphorylation Isoforms of b-Catenin
on the Regulation of b-Catenin
Distribution and Function
Given that ectopic and endogenous b-catenin can compete
for binding to different protein partners, we asked whether
different phosphorylation isoforms of wild-type b-catenin
may also compete for interactions with one such protein
partner, N-cadherin. We demonstrate that phosphoryla-
tion of b-catenin by Xgsk-3 increases the ability of phos-
phorylated relative to nonphosphorylated b-catenin to
bind to microsomes containing the cytoplasmic domain of
N-cadherin. This result shows that competition between
different phosphorylation isoforms of b-catenin can occur
in vitro. Therefore, differential phosphorylation and com-
petition may be an important mechanism by which cells
regulate the interaction of b-catenin with different part-
ners, thereby determining its function and subcellular dis-
tribution. Consistent with this idea, b-catenin and Arma-
dillo are often highly phosphorylated in cells, and the
regulation of tyrosine phosphorylation of b-catenin may
regulate adherens junction organization and cadherin
function (for review see Miller and Moon, 1996). Further-
more, both tyrosine- and serine/threonine-phosphorylated
forms of Armadillo preferentially associate with mem-
brane fractions compared to soluble, cytosolic fractions
(Peifer et al., 1994), consistent with the results presented
here and the evidence that cytoplasmic phosphorylated
b-catenin is quickly targeted for degradation (Yost et al.,
1996). In addition to promoting interactions with cadherin,
phosphorylation of b-catenin by Xgsk-3 or other intracel-
lular kinases may also modulate the association of b-cate-
nin with other protein partners, thereby regulating both
b-catenin function and its subcellular distribution. Further
experiments will likely uncover possible connections be-
tween b-catenin phosphorylation and their effects on its
binding interactions with different protein partners.
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